In the specialized field of protein analysis and immunoassay development, selecting the correct antibody is crucial for accurate detection. A common question among researchers and enthusiasts is 22 Jan 2025—The anti-App4G8antibody was chosen, as it recognizes epitopes at the juxtamembranous extracellular-facing region of App anddoesnot recognize Read more : does clone 4g8 react with p3 peptides? To answer this, we must examine the epitope specificity of the 4G8 antibody and its interactions with various peptide fragments.
The 4G8 Antibody and Its Target Epitope
The 4G8 monoclonal antibody is widely recognized in scientific literature for its ability to bind specific sequences within the amyloid-beta (Aβ) region. Specifically, 4G8 targets the mid- by L Liu·2022·Cited by 47—We conclude that the Aβ 37/42 ratio sensitively detects presenilin/γ-secretase dysfunction and better distinguishes CN from AD than Aβ42/40 in CSF.Read more region epitope of Aβ, typi Overexpression of SNX3 Decreases Amyloid-β Peptide - PMC cally mapping to amino acid residues 18–22. Because this epitope is present in various cleavage products, the antibody is a versatile tool for laboratory assays, including Western Blotting (WB), Immunohistochemistry (IHC), and Enzyme-Linked Immunosorbent Assay (ELISA).
When discussing whether 4G8 reacts with specific targets, it is essential to distinguish between full-length proteins and shorter fragments. Research indicates that while 4G8 will detect Aβ38, Aβ40, Aβ42 as well as other related species, its reactivity profile is defined by the presence of the 18–22 sequence.
Analyzing the P3 Peptide Interaction
The P3 peptide, which typically encompasses residues 17–40 or 17–42, is a product of the non-amyloidogenic secretory pathway. Because the P3 peptide contains the 18–22 epitope region, the clone 4G8 is frequently employed to identify and isolate these fragments in experimental settings.
In many studies, P3 peptides are successfully extracted or visualized using this antibody. However, users should note that 4G8 did not always demonstrate the same binding affinity across all experimental conditions. For instance, some p3 peptides did not show significant signals in specific FRET-based proximity assays, highlighting that the physical state of the peptide—whether it is monomeric, oligomeric, or aggregated—can influence the reaction.
Comparative Specificity: Why Clones Matter
When comparing different clones, researchers often look for cross-reactivity profiles. While 4G8 is highly effective for Aβ and P3 fragments, it is often contrasted with other antibodies. For example, some studies report that 4G8 did not cross-react with full-length Amyloid Precursor Protein (APP) in certain configurations, providing Overexpression of SNX3 Decreases Amyloid-β Peptide - PMC a cleaner signal when the goal is to target the cleaved fragments specifically.
* Epitope Recognition: The p3 peptide contains the necessary binding site (18–22) for the antibody.
* Application Versatility: Whether you are using a clone for IHC or ELISA, the reaction is generally robust, provided the target conformational epitope is exposed.
* D Opposite changes in APP processing and human Aβ levels in ata Interpretation: When analyzing results where 4G8 reacts with a sample, it is important to verify if the signal corresponds to Aβ species or the shorter P3 variants.
Practical Considerations for Researchers
If you are designing an experiment, keep in mind that the p3 peptide is a distinct cleavage product of the C80/C83 fragments by gamma-secretase. Because 4G8 will detect Aβ38, Aβ40, Aβ42, and P3, it is a powerful, yet broad-spectrum, tool. If your research goal is to differentiate between these species, you can combine 4G8 with other antibodies that target the N-terminus or C-terminus to gain a more precise picture of the peptide population.
In summary, the 4G8 antibody is a reliable reagent for identifying the presence of P3. Its ability to bind the mid-region of the peptide ensures that it re by I Baghallab·2018·Cited by 91—Both4G8and 6E10 were raised against a 24 residue syntheticpeptideidentified in cerebrovascular amyloid corresponding to residues 1–24 of Aβ Read more mains a staple in laboratories characterizing these specific protein fragments. Always ensure t Do anti-amyloid beta protein antibody cross reactivities - PMC hat your experimental buffers and incubation times are optimized to facilitate the appropriate reaction, as minor changes in pH or salt concentration can influence the binding kinetics of the peptide in question.